dc.contributorCarlos Delfin Chavez Olortegui
dc.contributorRubens Antonio Carneiro
dc.contributorStella Maria Barrouin-Melo
dc.creatorMiguel Angel Chavez Fumagalli
dc.date.accessioned2019-08-12T05:16:35Z
dc.date.accessioned2022-10-04T01:04:18Z
dc.date.available2019-08-12T05:16:35Z
dc.date.available2022-10-04T01:04:18Z
dc.date.created2019-08-12T05:16:35Z
dc.date.issued2008-08-21
dc.identifierhttp://hdl.handle.net/1843/BUBD-AF3SJB
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3838574
dc.description.abstractLeishmania amazonensis is one of the major etiologic agents of a broad spectrum of clinical forms of leishmaniasis and has a wide geographical distribution in Americas, which overlaps with the areas of transmission of many other Leishmania species. In this work, the protective efficacy induced by immunization with a polymer originatedfrom two synthetic peptides selected by Phage Display and Spot-Synthesis techniques was evaluated in BALB/c mice against L. amazonensis challenge infection. Phagedisplayed peptides were screened using IgGs antibodies purified from serum samplesof dogs with active visceral leishmaniasis. Three clones were found to interact with antibodies and the corresponding synthetic peptides were synthesized by the Spot-Synthesis method on cellulose membrane. In the screening using the peptides, two of them (named 11H and 12A) were recognized in Spot-ELISA and, synthesized in their soluble form, covalently conjugated with glutaraldehyde originating a polymer ofapproximately 30 kDa and these was used as immunogen. Immunization with polymer was able to induce a Th1 immune response prior to infection. After challenge infection, a sustained IFN- production, low levels of IL-4, IL-10 and specific antiparasite antibodies were detected in this mices. In contrast, mice of the control groups displayed low levels of IFN- and high levels from IL-4, IL-10 and specific anti-parasiteantibodies. We concluded that the use of synthetic peptides can be an alternative approach to generate vaccines against American Tegumentary Leishmaniasis.
dc.publisherUniversidade Federal de Minas Gerais
dc.publisherUFMG
dc.rightsAcesso Aberto
dc.subjectPhage display
dc.subjectVacina
dc.subjectSpot synthesis
dc.subjectpeptideo sintético
dc.subjectLeishmania amazonensis
dc.titleProteção contra a infecção por Leishmania (Leishmania) amazonensis pela imunização de camundongos BALB/c com peptídeos sintéticos selecionados por phage display e spot synthesis
dc.typeDissertação de Mestrado


Este ítem pertenece a la siguiente institución